Hims & Hers has acquired a U.S.-based peptide facility to advance its personalized treatments and stake a claim in peptide innovation.
Earlier this week, the Hims & Hers announced its acquisition of Trybe Labs, a New Jersey-based at-home lab testing facility, as it enters the whole body testing space and new areas, such as low testosterone treatment and perimenopausal and menopausal support.
“The future of healthcare must be centered on the customer, which is why our operational structure is built to scale personalized care to more individuals at the highest standard of quality and safety, and with a focus on long-term consistency and availability,” Hims & Hers chief operating officer Melissa Baird said. “We’re building our supply chain to enable more Americans to access care, including personalized treatments designed around their needs. This acquisition is a reflection of our commitment to those goals and our ongoing investment in the customer from start to finish.”
It’s been a busy month for the health and wellness platform. During Super Bowl LIX, Hims & Hers ran it’s first-ever “big game” commercial, reminding viewers that 74% of Americans are overweight while taking aim at high-priced weight loss medications to the backdrop of “This is America” by Childish Gambino.
“There are medications that work, but they’re priced for profits, not patients,” a narrator said during the spot. “This system wasn’t built to help us. It was built to keep us sick and stuck. But not anymore.”
The ad then highlighted Hims & Hers’ offerings, including affordable, U.S.-formulated weight loss medications and personalized treatment plans.
